These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 17127261)

  • 1. Roles of transglutaminases in cardiac and vascular diseases.
    Sane DC; Kontos JL; Greenberg CS
    Front Biosci; 2007 Jan; 12():2530-45. PubMed ID: 17127261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic Resonance Imaging Reveals Distinct Roles for Tissue Transglutaminase and Factor XIII in Maternal Angiogenesis During Early Mouse Pregnancy.
    Cohen G; Hadas R; Stefania R; Pagoto A; Ben-Dor S; Kohen F; Longo D; Elbaz M; Dekel N; Gershon E; Aime S; Neeman M
    Arterioscler Thromb Vasc Biol; 2019 Aug; 39(8):1602-1613. PubMed ID: 31189431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transglutaminase 2 limits the extravasation and the resultant myocardial fibrosis associated with factor XIII-A deficiency.
    Griffin KJ; Newell LM; Simpson KR; Beckers CML; Drinkhill MJ; Standeven KF; Cheah LT; Iismaa SE; Grant PJ; Jackson CL; Pease RJ
    Atherosclerosis; 2020 Feb; 294():1-9. PubMed ID: 31874419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in understanding the roles of transglutaminase 2 in alcoholic steatohepatitis.
    Tatsukawa H; Kojima S
    Cell Biol Int; 2010 Feb; 34(3):325-34. PubMed ID: 20192918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues.
    Greenberg CS; Birckbichler PJ; Rice RH
    FASEB J; 1991 Dec; 5(15):3071-7. PubMed ID: 1683845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue transglutaminase and factor XIII in cartilage and bone remodeling.
    Aeschlimann D; Mosher D; Paulsson M
    Semin Thromb Hemost; 1996; 22(5):437-43. PubMed ID: 8989828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue transglutaminase (TG2)--a wound response enzyme.
    Telci D; Griffin M
    Front Biosci; 2006 Jan; 11():867-82. PubMed ID: 16146777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the Catalytic Activity of Transglutaminases in the Context of Autophagic Responses.
    D'Eletto M; Farrace MG; Piacentini M; Rossin F
    Methods Enzymol; 2017; 587():511-520. PubMed ID: 28253975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of transglutaminase-2 and its substrates in human diseases.
    Facchiano F; Facchiano A; Facchiano AM
    Front Biosci; 2006 May; 11():1758-73. PubMed ID: 16368554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous activity assay of two transglutaminase isozymes, blood coagulation factor XIII and transglutaminase 2, by use of fibrinogen arrays.
    Kwon MH; Jung SH; Kim YM; Ha KS
    Anal Chem; 2011 Nov; 83(22):8718-24. PubMed ID: 21961727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transglutaminases in vascular biology: relevance for vascular remodeling and atherosclerosis.
    Bakker EN; Pistea A; VanBavel E
    J Vasc Res; 2008; 45(4):271-8. PubMed ID: 18212504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transglutaminase 2 inhibitors and their therapeutic role in disease states.
    Siegel M; Khosla C
    Pharmacol Ther; 2007 Aug; 115(2):232-45. PubMed ID: 17582505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor XIII (FXIII) and angiogenesis.
    Dardik R; Loscalzo J; Inbal A
    J Thromb Haemost; 2006 Jan; 4(1):19-25. PubMed ID: 16129024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of transglutaminases by nitric oxide.
    Bernassola F; Rossi A; Melino G
    Ann N Y Acad Sci; 1999; 887():83-91. PubMed ID: 10668466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multiple functions of transglutaminases].
    Hasegawa G; Saito Y
    Tanpakushitsu Kakusan Koso; 2004 Apr; 49(5):642-8. PubMed ID: 15071895
    [No Abstract]   [Full Text] [Related]  

  • 16. Transglutaminase 2: biology, relevance to neurodegenerative diseases and therapeutic implications.
    Grosso H; Mouradian MM
    Pharmacol Ther; 2012 Mar; 133(3):392-410. PubMed ID: 22212614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gα(h)/transglutaminase-2 activity is required for maximal activation of adenylylcyclase 8 in human and rat glioma cells.
    Obara Y; Yanagihata Y; Abe T; Dafik L; Ishii K; Nakahata N
    Cell Signal; 2013 Mar; 25(3):589-97. PubMed ID: 23200849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytosolic guanine nucledotide binding deficient form of transglutaminase 2 (R580a) potentiates cell death in oxygen glucose deprivation.
    Colak G; Keillor JW; Johnson GV
    PLoS One; 2011 Jan; 6(1):e16665. PubMed ID: 21304968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
    Achyuthan KE; Dobson JV; Greenberg CS
    Biochim Biophys Acta; 1986 Aug; 872(3):261-8. PubMed ID: 2873839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transglutaminase 2 deficiency decreases plaque fibrosis and increases plaque inflammation in apolipoprotein-E-deficient mice.
    Van Herck JL; Schrijvers DM; De Meyer GR; Martinet W; Van Hove CE; Bult H; Vrints CJ; Herman AG
    J Vasc Res; 2010; 47(3):231-40. PubMed ID: 19893320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.